Douglas Onsi

Investor type:

Social media:

Available after registration.

Past investments

  • Apofore
  • Catalyst Biosciences
  • Avidia
  • Proteostasis Therapeutics
  • GlobeImmune
  • DecImmune Therapeutics
  • Colorescience
  • Stemgent
  • Mosaic Biosciences
  • Tensha Therapeutics
  • Xanodyne
  • Orqis Medical
  • Endomedix
  • InfaCare Pharmaceutical
  • Tolerx
  • Cool Energy
  • Ascent Therapeutics
  • Dicerna Pharmaceuticals
  • Radius Health
  • Arresto BioSciences
  • Critical Therapeutics,Inc.
  • Trevena
  • PharmAthene
  • BIKAM Pharmaceuticals
  • Adheron Therapeutics
  • Xanthus Pharmaceuticals
  • Seahorse Bioscience
  • CellGate
  • Sierra Neuropharmaceuticals Inc.
  • CellNovo
  • Galleon Pharmaceuticals
  • RedPath Integrated Pathology
  • MiddleBrook Pharmaceuticals, Inc
  • Anchor Therapeutics
  • nanoMR
  • Cardiokine
  • Sequoia Pharmaceuticals
  • Vaxxas
  • Apellis Pharmaceuticals
  • Dynogen Pharmaceuticals
  • Theraclone Sciences
  • Aciex Therapeutics
  • Senseonics
  • SkinMedica
  • VaxInnate
  • Shape Pharmaceuticals
  • Pathogenetix
  • BioProcessors
  • Cleveland HeartLab
  • Anexon
  • TetraLogic Pharmaceuticals
  • Leap Therapeutics
  • Foldrx Pharmaceuticals
  • Promedior
  • Antisoma
  • GITR